A monocentric, single arm, open-label prospective clinical study to assess the efficacy of Intimate Lightening Skin Cream in healthy adult human female subjects.

Arbro Pharmaceutical Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年1月22日

试验速览

暂无简介。

•Subjects must meet all of the following criteria in order to be included in the study.
•1 Subject in generally good health.
•2 Subject between the age group of 18 and 45 years.
•3 Subject has not participated in a similar clinical investigation in the past four weeks.
•4 Subject willing to abstain from using any product, besides the provided product during the entire study course.
•5 Subject willing to visit the site at specified frequencies for periodic evaluations.
•6 Subject willing to comply with study specific requirements.
•7 Subject willing to give a written informed consent and come for regular observation.

•Subjects meeting any of the following criteria must be excluded from enrolment in the study.
•1 A known history or present condition of allergic response to any Cosmetic products.
•2 Subject with known allergy/ sensitivity to cosmetic products or fragrance and without any skin allergies infections.
•3 Subject under any dermatological treatment / prescribed medications.
•4 Skin disease (e.g. psoriasis, atopic dermatitis or other cutaneous manifestations on the scalp), which would interfere with the test readings.
•5 Any cutaneous conditions on the test site (scars, moles, papules etc.)
•6 On medications (e.g. steroids or antihistamines), which would compromise the study.
•7 Currently or has been undergoing dermatologist treatments or procedures within the last 1 month.
•8 Subject viewed by the investigator as not being able to complete the study or participating in another study.

发起方

Arbro Pharmaceutical Private Limited